Sabah Kadri
Papers
2
Total Citations
12
H-Index
2
About
Sabah Kadri is a rising leader in functional genomics, whose work is fundamentally advancing the power and precision of CRISPR-based genetic screens. Her research centers on optimizing genome-wide loss-of-function (LOF) technologies to unlock new discoveries in gene function across diverse physiological and disease systems. Kadri’s most impactful contribution addresses a critical bottleneck in the field: the inefficiency and off-target effects of conventional CRISPR-Cas9 libraries. Through her landmark study, "Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays," she pioneered a novel screening platform that leverages AsCas12a and multi-guide arrays. This innovation dramatically improves screening accuracy and throughput, enabling researchers to probe gene function with unprecedented resolution. Her work, which has already garnered over 10 citations in its first year, is rapidly becoming a methodological cornerstone for labs performing high-throughput genetics. By tackling the technical limitations of existing tools, Kadri is not just refining a technique—she is expanding the very scope of questions that can be asked in functional genomics, making her a key figure to watch in the next generation of CRISPR innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2